cancer weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of cancer weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Collaborations
Company announces expansion of relationship with Pfizer
December 14th, 2004
Genstruct, Inc., has signed an agreement with Pfizer to collaborate on a variety of research projects to help better understand complex diseases. This deal is part of a continuing, multiyear relationship Genstruct has developed with Pfizer. Terms of the partnership are not being disclosed. This new arrangement will include research projects with several Pfizer units, including worldwide safety sciences, the proteomics global center of excellence, and clinical sciences. Genstruct will use its Molecular Epistemics Platform to generate hypotheses to reveal underlying mechanisms of action and toxicity to help Pfizer prioritize and develop new medicines...
Source: cancer weekly (2004-12-14)
|
